Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 125 citing articles:

Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis
Tamara Pérez-Jeldres, Manuel Álvarez-Lobos, Jesús Rivera–Nieves
Drugs (2021) Vol. 81, Iss. 9, pp. 985-1002
Open Access | Times Cited: 143
Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
Rongzeng Liu, Shushu Du, Lili Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 79
Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate
Shian Liu, Navid Paknejad, Lan Zhu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 74
Understanding the therapeutic toolkit for inflammatory bowel disease
Sophie Vieujean, Vipul Jairath, Laurent Peyrin‐Biroulet, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access | Times Cited: 4
Nitrile-containing pharmaceuticals: target, mechanism of action, and their SAR studies
Xi Wang, Yuanxun Wang, Xuemin Li, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 10, pp. 1650-1671
Open Access | Times Cited: 102
Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases
Hongyu Chen, Junmin Wang, Caiyun Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113341-113341
Open Access | Times Cited: 45
Hippo signaling pathway and respiratory diseases
Weifeng Tang, Min Li, Xiaoting Yangzhong, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 43
Structure of S1PR2–heterotrimeric G 13 signaling complex
Hongwen Chen, Kevin Y. Chen, Weijiao Huang, et al.
Science Advances (2022) Vol. 8, Iss. 13
Open Access | Times Cited: 42
Clinician’s Guide to Using Ozanimod for the Treatment of Ulcerative Colitis
Bruce E. Sands, Stefan Schreiber, Irina Blumenstein, et al.
Journal of Crohn s and Colitis (2023) Vol. 17, Iss. 12, pp. 2012-2025
Open Access | Times Cited: 27
An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis
Laura Dumitrescu, Αθανάσιος Παπαθανασίου, Catalina Coclitu, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 4, pp. 495-509
Open Access | Times Cited: 26
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension
Silvio Danese, Remo Panaccione, María T. Abreu, et al.
Journal of Crohn s and Colitis (2023) Vol. 18, Iss. 2, pp. 264-274
Open Access | Times Cited: 26
Sphingosine-1-Phosphate Signaling in Cardiovascular Diseases
Na Wang, Jingyi Li, Bo Zeng, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 818-818
Open Access | Times Cited: 24
Sphingosine 1‐phosphate receptor modulators in multiple sclerosis treatment: A practical review
Patricia K. Coyle, Mark S. Freedman, Bruce A. Cohen, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 4, pp. 842-855
Open Access | Times Cited: 14
Sphingolipids as Modulators of SARS-CoV-2 Infection
Kid Törnquist, Muhammad Yasir Asghar, Vignesh Srinivasan, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 54
Secondary mechanisms of injury and viable pathophysiological targets in intracerebral hemorrhage
Wendy Bautista, P. David Adelson, Nathan Bicher, et al.
Therapeutic Advances in Neurological Disorders (2021) Vol. 14
Open Access | Times Cited: 50
Current Knowledge on the Biology of Lysophosphatidylserine as an Emerging Bioactive Lipid
Jumpei Omi, Kuniyuki Kano, Junken Aoki
Cell Biochemistry and Biophysics (2021) Vol. 79, Iss. 3, pp. 497-508
Open Access | Times Cited: 39
The Two Sides of Siponimod: Evidence for Brain and Immune Mechanisms in Multiple Sclerosis
Stanley Cohan, Ralph H. B. Benedict, Bruce Cree, et al.
CNS Drugs (2022) Vol. 36, Iss. 7, pp. 703-719
Open Access | Times Cited: 24
Transmembrane protein CD69 acts as an S1PR1 agonist
Hongwen Chen, Qin Yu, Marissa Chou, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 14
The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing–Remitting and Secondary Progressive Multiple Sclerosis
Martin Vališ, Anat Achiron, Hans Hartung, et al.
Drugs in R&D (2023) Vol. 23, Iss. 4, pp. 331-338
Open Access | Times Cited: 13
Re-establishing immune tolerance in multiple sclerosis: focusing on novel mechanisms of mesenchymal stem cell regulation of Th17/Treg balance
Huiru Hu, Hui Li, Ruoyu Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review
Victor Constantinescu, Rocco Haase, Katja Akgün, et al.
Therapeutic Advances in Neurological Disorders (2022) Vol. 15
Open Access | Times Cited: 19
An overview of sphingosine‐1‐phosphate receptor 2: Structure, biological function, and small‐molecule modulators
Wanting Hao, Dongdong Luo, Yuqi Jiang, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2331-2362
Closed Access | Times Cited: 4
Advancements in ulcerative colitis management: A critical assessment of etrasimod therapy
Kushal Seni, Aniket Saini, Rabin Debnath, et al.
Health Sciences Review (2024) Vol. 12, pp. 100196-100196
Open Access | Times Cited: 4
Atypical sphingosine-1-phosphate metabolites—biological implications of alkyl chain length
Melanie Glueck, Alexandra Lucaciu, Julien Subburayalu, et al.
Pflügers Archiv - European Journal of Physiology (2024)
Open Access | Times Cited: 4
PET Imaging of Sphingosine-1-Phosphate Receptor 1 with [18F]TZ4877 in Nonhuman Primates
Jiwei Gu, Ming‐Qiang Zheng, Daniel Holden, et al.
Molecular Imaging and Biology (2025) Vol. 27, Iss. 1, pp. 54-63
Open Access
Page 1 - Next Page

Scroll to top